Raul Villa M.D. Mph

Raul Villa, MD MPH has a strong background in drug safety and pharmacovigilance. Raul started their career in 2000 at sanofi-aventis as a Global Safety Officer, where they worked until 2007. From there, they joined Bristol-Myers Squibb as a Director of Medical Safety for the Cardio-Metabolic therapeutic area, and stayed until 2009. Raul then moved on to Merck, where they worked as the Director of Clinical Risk Management until 2011.

In 2011, Raul joined Cubist Pharmaceuticals as a Senior Medical Director, overseeing Global Pharmacovigilance and Medical Risk Management. Raul held this position until 2014, when they joined Theravance Biopharma US, Inc. as the Head of Clinical Safety and Pharmacovigilance. Raul remained in this role until 2019.

Currently, Raul is the Vice President and Global Head of Drug Safety and Pharmacovigilance at Insmed Incorporated.

Raul Villa, MD MPH completed a Bachelor of Science degree with an accelerated program at the University of Santo Tomas. The specific field of study for this degree is not provided. Following this, they pursued further education at the same institution and obtained a medical degree (MD) in Medicine and Surgery. Later, Raul attended Rutgers University where they completed a Master of Public Health (MPH) degree, specializing in Epidemiology. The exact start and end years for each of these education experiences are not provided.